New study explores Fasting's impact on stomach content in obesity drug users
NCT ID NCT07225816
First seen Nov 11, 2025 · Last updated Jun 16, 2026 · Updated 32 times
Summary
This study looks at how long you need to fast and whether pausing GLP-1 weight-loss drugs (like liraglutide or semaglutide) changes how much food stays in your stomach after a high-fat meal. It involves 75 adults already taking these medications. The goal is to better understand stomach emptying to improve safety and guidance for people using these treatments.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Altasciences Clinical LA, Inc.
RECRUITINGCypress, California, 90630, United States
Conditions
Explore the condition pages connected to this study.